Spaceflight, genetic tinkering, and the psychological implications of technological acceleration are explored with accuracy ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...

Goldenberries taste like a cross between pineapple and mango, pack the nutritional punch of a superfood, and are increasingly ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...

The outlook for dementia care is changing fast. UC experts explain what that means for patients and families, and what it ...

An archaeon reads the same codon in two different ways, overturning a doctrine that has stood for 60 years. Living organisms ...

New research published in Nature Communications has linked a normal cellular process to an accumulation of DNA mutations in ...

For the scientific enterprise, 2025 was marked by setbacks and challenges. But scientists are no strangers to adversity—the ability to overcome obstacles is built into our training. In turn, research ...

Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...

Nearly three decades since the remarkable cloning of Dolly the sheep, it has all gone quiet on the human cloning front.

A rare disease mom and scientist shares on the "First Opinion Podcast" how she serves as a translator between her two ...